Do you check AMH levels to decide on adjuvant chemotherapy in premenopausal patients with node-positive ER+ breast cancer?
Did the ASCO 2024 presentation from RxPONDER change your practice?
Community PollStarted
How are you utilizing AMH levels in premenopausal pts with Node+ HR+ breast cancer?
28 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Northwell Health-Lenox Hill Hospital
Answered on · Updated on
The short answer is no. The decision to recommend adjuvant chemotherapy for premenopausal, node-positive, ER+ breast cancer is based on the tumor's biology, not the patient's AMH levels. Here are my thoughts:
Role of AMH: AMH levels are not used to decide on chemotherapy. They are used to counsel pa...
Join for free or sign in to see the full answer